SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001728117-21-000071
Filing Date
2021-06-14
Accepted
2021-06-14 16:22:46
Documents
14
Period of Report
2021-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K goss-20210609.htm   iXBRL 8-K 59409
2 EX-99.1 exhibit991.htm EX-99.1 5502
6 GRAPHIC image_0.jpg GRAPHIC 161740
  Complete submission text file 0001728117-21-000071.txt   428412

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20210609.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20210609_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20210609_pre.xml EX-101.PRE 12652
7 EXTRACTED XBRL INSTANCE DOCUMENT goss-20210609_htm.xml XML 10767
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 211014857
SIC: 2834 Pharmaceutical Preparations